Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Procalcitonin-guided antibiotic treatment in patients with cancer: a patient-level meta-analysis from randomized controlled trials.
Gregoriano C, Wirz Y, Heinsalo A, Annane D, Reinhart K, Bouadma L, Christ-Crain M, Kristoffersen KB, Damas P, Nobre V, Oliveira CF, Shehabi Y, Stolz D, Verduri A, Mueller B, Schuetz P. Gregoriano C, et al. Among authors: shehabi y. BMC Cancer. 2024 Nov 28;24(1):1467. doi: 10.1186/s12885-024-13160-2. BMC Cancer. 2024. PMID: 39609770 Free PMC article.
Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial.
Rogers BA, Fowler R, Harris PNA, Davis JS, Pinto RL, Bhatia Dwivedi D, Rishu A, Shehabi Y, Daneman N. Rogers BA, et al. Among authors: shehabi y. BMJ Open. 2023 Jun 26;13(6):e069708. doi: 10.1136/bmjopen-2022-069708. BMJ Open. 2023. PMID: 37369422 Free PMC article.
The effect of dexmedetomidine on vasopressor requirements in patients with septic shock: a subgroup analysis of the Sedation Practice in Intensive Care Evaluation [SPICE III] Trial.
Cioccari L, Luethi N, Bailey M, Shehabi Y, Howe B, Messmer AS, Proimos HK, Peck L, Young H, Eastwood GM, Merz TM, Takala J, Jakob SM, Bellomo R; ANZICS Clinical Trials Group and the SPICE III Investigators. Cioccari L, et al. Among authors: shehabi y. Crit Care. 2020 Jul 16;24(1):441. doi: 10.1186/s13054-020-03115-x. Crit Care. 2020. PMID: 32678054 Free PMC article. Clinical Trial.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial.
Writing Committee for the REMAP-CAP Investigators; Higgins AM, Berry LR, Lorenzi E, Murthy S, McQuilten Z, Mouncey PR, Al-Beidh F, Annane D, Arabi YM, Beane A, van Bentum-Puijk W, Bhimani Z, Bonten MJM, Bradbury CA, Brunkhorst FM, Burrell A, Buzgau A, Buxton M, Charles WN, Cove M, Detry MA, Estcourt LJ, Fagbodun EO, Fitzgerald M, Girard TD, Goligher EC, Goossens H, Haniffa R, Hills T, Horvat CM, Huang DT, Ichihara N, Lamontagne F, Marshall JC, McAuley DF, McGlothlin A, McGuinness SP, McVerry BJ, Neal MD, Nichol AD, Parke RL, Parker JC, Parry-Billings K, Peters SEC, Reyes LF, Rowan KM, Saito H, Santos MS, Saunders CT, Serpa-Neto A, Seymour CW, Shankar-Hari M, Stronach LM, Turgeon AF, Turner AM, van de Veerdonk FL, Zarychanski R, Green C, Lewis RJ, Angus DC, McArthur CJ, Berry S, Derde LPG, Gordon AC, Webb SA, Lawler PR. Writing Committee for the REMAP-CAP Investigators, et al. JAMA. 2023 Jan 3;329(1):39-51. doi: 10.1001/jama.2022.23257. JAMA. 2023. PMID: 36525245 Free PMC article.
Postoperative delirium under general anaesthesia by remimazolam versus propofol: A systematic review and meta-analysis of randomised controlled trials.
Suga M, Yasuhara J, Watanabe A, Takagi H, Kuno T, Nishimura T, Ijuin S, Taira T, Inoue A, Ishihara S, Pakavakis A, Glassford N, Shehabi Y. Suga M, et al. Among authors: shehabi y. J Clin Anesth. 2025 Feb;101:111735. doi: 10.1016/j.jclinane.2024.111735. Epub 2024 Dec 30. J Clin Anesth. 2025. PMID: 39832842 Review.
Hospital-level volume in extracorporeal membrane oxygenation cases and death or disability at 6 months.
Ertugrul AD, Neto AS, Fulcher BJ, Charles-Nelson A, Bailey M, Burrell AJC, Anderson S, Bernard S, Board JV, Brodie D, Buhr H, Cooper DJ, Dicker C, Fan E, Fraser JF, Gattas DJ, Hopper IK, Huckson S, Linke NJ, Litton E, McGuinness SP, Nair P, Orford N, Parke RL, Pellegrino VA, Pilcher DV, Stub D, Udy AA, Reddi BAJ, Trapani TV, Jones A, Higgins AM, Hodgson CL; EXCEL Study Investigators and the International ECMO Network (ECMONet). Ertugrul AD, et al. Crit Care Resusc. 2024 Nov 22;26(4):262-270. doi: 10.1016/j.ccrj.2024.08.006. eCollection 2024 Dec. Crit Care Resusc. 2024. PMID: 39781494 Free PMC article.
The impact of a tailored nutrition intervention delivered for the duration of hospitalisation on daily energy delivery for patients with critical illness (INTENT): a phase II randomised controlled trial.
Ridley EJ, Bailey M, Chapman MJ, Chapple LS, Deane AM, Gojanovic M, Higgins AM, Hodgson CL, King VL, Marshall AP, Miller EG, McGuinness SP, Parke RL, Paul E, Udy AA; Australian, New Zealand Intensive Care Society Clinical Trials Group. Ridley EJ, et al. Crit Care. 2025 Jan 6;29(1):8. doi: 10.1186/s13054-024-05189-3. Crit Care. 2025. PMID: 39762887 Free PMC article. Clinical Trial.
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections.
BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network; Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, Cook D, Arabi Y, Muscedere J, Reynolds S, Hall R, Dwivedi DB, McArthur C, McGuinness S, Yahav D, Coburn B, Geagea A, Das P, Shin P, Detsky M, Morris A, Fralick M, Powis JE, Kandel C, Sligl W, Bagshaw SM, Singhal N, Belley-Cote E, Whitlock R, Khwaja K, Morpeth S, Kazemi A, Williams A, MacFadden DR, McIntyre L, Tsang J, Lamontagne F, Carignan A, Marshall J, Friedrich JO, Cirone R, Downing M, Graham C, Davis J, Duan E, Neary J, Evans G, Alraddadi B, Al Johani S, Martin C, Elsayed S, Ball I, Lauzier F, Turgeon A, Stelfox HT, Conly J, McDonald EG, Lee TC, Sullivan R, Grant J, Kagan I, Young P, Lawrence C, O'Callaghan K, Eustace M, Choong K, Aslanian P, Buehner U, Havey T, Binnie A, Prazak J, Reeve B, Litton E, Lother S, Kumar A, Zarychanski R, Hoffman T, Paterson D, Daley P, Commons RJ, Charbonney E, Nau… See abstract for full author list ➔ BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network, et al. Among authors: shehabi y. N Engl J Med. 2024 Nov 20. doi: 10.1056/NEJMoa2404991. Online ahead of print. N Engl J Med. 2024. PMID: 39565030
Procalcitonin-Guided Management and Duration of Antibiotic Therapy in Critically Ill Cancer Patients With Sepsis (Pro-Can Study): A Randomized Controlled Trial.
Nazer LH, Awad W, Thawabieh H, Abusara A, Abdelrahman D, Addassi A, Abuatta O, Sughayer M, Shehabi Y. Nazer LH, et al. Among authors: shehabi y. Crit Care Explor. 2024 Oct 21;6(10):e1173. doi: 10.1097/CCE.0000000000001173. eCollection 2024 Oct 1. Crit Care Explor. 2024. PMID: 39431961 Free PMC article. Clinical Trial.
169 results